UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008377 |
|---|---|
| Receipt number | R000009848 |
| Scientific Title | Phase II clinical trial of Cetuximab with Fluorouracil therapy for patients refractory or intolerable to Oxaliplatin and Irinotecan with KRAS wild-type unresectable/recurrent colorectal cancer |
| Date of disclosure of the study information | 2012/07/08 |
| Last modified on | 2018/06/25 14:56:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/07/08 15:51:48 | ||
| 2 | Update | 2012/07/08 15:56:48 | Date of disclosure of the study information |
|
| 3 | Update | 2012/07/08 15:59:12 | Organization Organization |
|
| 4 | Update | 2013/01/05 11:02:49 | Recruitment status |
|
| 5 | Update | 2013/01/06 05:36:39 | Organization Organization Organization Institute Organization |
|
| 6 | Update | 2014/07/08 14:05:00 | Email |
|
| 7 | Update | 2018/06/25 14:56:51 | Recruitment status Date of protocol fixation Anticipated trial start date |
